Samsung BioLogics says report on Biogen deal talks untrue
Dec 29 (Reuters) - Samsung BioLogics (207940.KS) on Thursday denied a media report that said the South Korean firm was in talks to buy U.S. drugmaker Biogen Inc (BIIB.O).Korea Economic Daily reported on Wednesday, citing investment…